The Role of Sodium-Glucose Cotransporter-2 Inhibition in Heart Failure with Preserved Ejection Fraction

The Role of Sodium-Glucose Cotransporter-2 Inhibition in Heart Failure with Preserved Ejection Fraction

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a novel class of antidiabetic mediations found to also reduce cardiovascular morbidity and mortality and hospitalization for heart failure. Positive results from the EMPEROR-Preserved (empagliflozin) and PRESERVED-HF (dapagliflozin) studies led t...

Full description

Bibliographic Details
Main Authors: Lindsay Brust-Sisti, Nicole Rudawsky, Jimmy Gonzalez, Luigi Brunetti
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pharmacy
Subjects:
heart failure
sodium-glucose transporter 2
dapagliflozin
empagliflozin
ertugliflozin
canagliflozin
Online Access:https://www.mdpi.com/2226-4787/10/6/166

Internet

https://www.mdpi.com/2226-4787/10/6/166

Similar Items